Literature DB >> 21884955

Chronic kidney disease and cardiovascular therapeutics: time to close the evidence gaps.

Tara I Chang, Glenn M Chertow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21884955      PMCID： PMC4109646          DOI： 10.1016/j.jacc.2011.06.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  22 in total

1.  High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database.

Authors:  J Thomas Heywood; Gregg C Fonarow; Maria Rosa Costanzo; Vandana S Mathur; John R Wigneswaran; Janet Wynne
Journal:  J Card Fail       Date:  2007-08       Impact factor: 5.712

2.  Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.

Authors:  F Zannad; M Kessler; P Lehert; J P Grünfeld; C Thuilliez; A Leizorovicz; P Lechat
Journal:  Kidney Int       Date:  2006-07-19       Impact factor: 10.612

Review 3.  Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Sunil V Badve; Matthew A Roberts; Carmel M Hawley; Alan Cass; Amit X Garg; Henry Krum; Andrew Tonkin; Vlado Perkovic
Journal:  J Am Coll Cardiol       Date:  2011-09-06       Impact factor: 24.094

4.  Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: a national Veterans Administration study.

Authors:  Eric M Gibney; Adrianne W Casebeer; Lynn M Schooley; Francesca Cunningham; Frederick L Grover; Missy R Bell; Gerald O McDonald; A Laurie Shroyer; Chirag R Parikh
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

5.  Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

Authors:  Keith Norris; Jacque Bourgoigne; Jennifer Gassman; Lee Hebert; John Middleton; Robert A Phillips; Otelio Randall; Stephen Rostand; Susan Sherer; Robert D Toto; Jackson T Wright; Xuelei Wang; Tom Greene; Lawrence J Appel; Julia Lewis
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

6.  Use of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care system.

Authors:  Kevin C Abbott; Erin M Bohen; Christina M Yuan; Frederick E Yeo; Eric S Sawyers; Robert M Perkins; Krista L Lentine; David K Oliver; Joanie Galey; Mary E Sebastianelli; John P Scally; Allen J Taylor; Thomas R Boal
Journal:  Am J Kidney Dis       Date:  2006-04       Impact factor: 8.860

Review 7.  Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.

Authors:  Steven G Coca; Harlan M Krumholz; Amit X Garg; Chirag R Parikh
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

8.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

9.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

10.  Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

Authors:  Michael G Shlipak; Paul A Heidenreich; Haruko Noguchi; Glenn M Chertow; Warren S Browner; Mark B McClellan
Journal:  Ann Intern Med       Date:  2002-10-01       Impact factor: 25.391
View more
  3 in total

Review 1.  Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature.

Authors:  Ali A Valika; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

2.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

3.  Beta-Blocker-Related Atrioventricular Conduction Disorders-A Single Tertiary Referral Center Experience.

Authors:  Dragoș Traian Marius Marcu; Cristina Andreea Adam; Dan-Mihai Dorobanțu; Delia Lidia Șalaru; Radu Andy Sascău; Mircea Ovanez Balasanian; Liviu Macovei; Cătălina Arsenescu-Georgescu; Cristian Stătescu
Journal:  Medicina (Kaunas)       Date:  2022-02-20       Impact factor: 2.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.